Northeast Pharmaceutical Group Co (SZSE:000597) Inventories, Work In Process: ¥109 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:000597 Northeast Pharmaceutical Group Co Ltd SZSE:000597
62 GF Score
Price ¥4.74
GF Value ¥4.21
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Northeast Pharmaceutical Group Co Inventories, Work In Process?

Northeast Pharmaceutical Group Co SZSE:000597 +0.64% 62 Inventories, Work In Process is ¥109 Mil as of Jun. 2026. GuruFocus rates SZSE:000597 with a GF Score™ of 62/100 and a GF Value™ of ¥4.21 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Northeast Pharmaceutical Group Co's work in process for the quarter that ended in Jun. 2026 was ¥109 Mil.

Northeast Pharmaceutical Group Co Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Northeast Pharmaceutical Group Co's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Northeast Pharmaceutical Group Co Inventories, Work In Process Chart

Northeast Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 156.16 132.77 160.84 135.35 156.81

Northeast Pharmaceutical Group Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 123.67 0.00 156.81 0.00 109.48
SZSE:000597
62GF Score
Northeast Pharmaceutical Group Co Ltd SZSE:000597
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Northeast Pharmaceutical Group Co Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of ¥109 Mil mean?
Northeast Pharmaceutical Group Co (SZSE:000597) has a Inventories, Work In Process of ¥109 Mil as of Jun. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Northeast Pharmaceutical Group Co and its competitors.
Is Northeast Pharmaceutical Group Co's Inventories, Work In Process too high?
Northeast Pharmaceutical Group Co's current Inventories, Work In Process is ¥109 Mil. Overall, Northeast Pharmaceutical Group Co has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Northeast Pharmaceutical Group Co's Inventories, Work In Process compare to ZTS?
Northeast Pharmaceutical Group Co's Inventories, Work In Process of ¥109 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Drug Manufacturers company?
A good Inventories, Work In Process depends on the Drug Manufacturers industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Northeast Pharmaceutical Group Co and its competitors. Northeast Pharmaceutical Group Co's current Inventories, Work In Process is ¥109 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Northeast Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Northeast Pharmaceutical Group Co (SZSE:000597) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥4.21, compared to a current price of ¥4.74 — trading 12.6% above its estimated fair value. The current Inventories, Work In Process is ¥109 Mil. Northeast Pharmaceutical Group Co's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Northeast Pharmaceutical Group Co (SZSE:000597), the current Inventories, Work In Process is ¥109 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Northeast Pharmaceutical Group Co (SZSE:000597) Overvalued in 2026?

Based on GuruFocus' analysis, Northeast Pharmaceutical Group Co stock appears to be overvalued. The current stock price of ¥4.74 is trading 12.6% above its estimated GF Value™ of ¥4.21. GuruFocus considers Northeast Pharmaceutical Group Co to be Modestly Overvalued.

Key valuation signals for SZSE:000597:

  • Inventories, Work In Process: ¥109 Mil
  • GF Value™: ¥4.21 vs. price of ¥4.74 (12.6% above fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the SZSE:000597 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Northeast Pharmaceutical Group Co Business Description

Address No. 8 Kunminghu Street, Economic and Technology Development Zone, Shenyang, Liaoning, CHN, 110027
Northeast Pharmaceutical Group Co Ltd is engaged in the production and distribution of ammonium phosphate, sulfuric acid, cement, compound fertilizer, bromine, raw salt, and diammonium phosphate.
62GF Score

Get the complete analysis for SZSE:000597

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.74
Price
¥4.21
GF Value